-CNBC’s “Fast Money: Halftime Report”
Why Novavax Stock Is Moving Today
Novavax, Inc. (NASDAQ: NVAX) shares are trading higher by 9.8% at $230.25 Monday morning after the company announced positive Phase 3 trial results for its COVID-19 vaccine.